Subretinal Drusenoid Deposits and Photoreceptor Loss Detecting Global and Local Progression of Geographic Atrophy by SD-OCT Imaging.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 06 2020
Historique:
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 2 1 2021
Statut: ppublish

Résumé

To investigate the impact of subretinal drusenoid deposits (SDD) and photoreceptor integrity on global and local geographic atrophy (GA) progression. Eighty-three eyes of 49 patients, aged 50 years and older with GA secondary to age-related macular degeneration (AMD), were prospectively included in this study. Participants underwent spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging at baseline and after 12 months. The junctional zone and presence of SDD were delineated on SD-OCT and FAF images. Linear mixed models were calculated to investigate the association between GA progression and the junctional zone area, baseline GA area, age, global and local presence of SDD and unifocal versus multifocal lesions. The area of the junctional zone was significantly associated with the progression of GA, both globally and locally (all P < 0.001). SDD were associated with faster growth in the overall model (P = 0.039), as well as in the superior-temporal (P = 0.005) and temporal (P = 0.002) sections. Faster progression was associated with GA baseline area (P < 0.001). No difference was found between unifocal and multifocal lesions (P > 0.05). Age did not have an effect on GA progression (P > 0.05). Photoreceptor integrity and SDD are useful for predicting global and local growth in GA. Investigation of the junctional zone is merited because this area is destined to become atrophic. Photoreceptor loss visible on SD-OCT might lead to new structural outcome measurements visible before irreversible loss of retinal pigment epithelium occurs.

Identifiants

pubmed: 32503052
pii: 2766309
doi: 10.1167/iovs.61.6.11
pmc: PMC7415285
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

Invest Ophthalmol Vis Sci. 2013 Nov 08;54(12):7362-9
pubmed: 24114542
Retina. 2014 Mar;34(3):576-82
pubmed: 24056526
IEEE Trans Med Imaging. 2019 Apr;38(4):1037-1047
pubmed: 30346281
Ophthalmology. 2020 Mar;127(3):394-409
pubmed: 31708275
Retina. 2013 Oct;33(9):1850-62
pubmed: 23632954
Retina. 2016 Dec;36 Suppl 1:S12-S25
pubmed: 28005660
Am J Ophthalmol. 2017 Jul;179:118-128
pubmed: 28385474
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3199-3208
pubmed: 29971444
Retina. 2018 Aug;38(8):1456-1463
pubmed: 28834947
Transl Vis Sci Technol. 2018 Dec 28;7(6):40
pubmed: 30619660
Retina. 2019 Oct;39(10):1829-1839
pubmed: 30829988
Eye (Lond). 2017 Jan;31(1):26-44
pubmed: 27886184
Am J Ophthalmol. 2014 Sep;158(3):584-96.e1
pubmed: 24907433
Retina. 2019 Apr;39(4):802-816
pubmed: 30839495
Retina. 2018 Oct;38(10):1937-1953
pubmed: 29746415
Mol Vis. 1999 Nov 03;5:25
pubmed: 10562649
Surv Ophthalmol. 2018 Nov - Dec;63(6):782-815
pubmed: 29859199
Ophthalmology. 2007 Feb;114(2):271-7
pubmed: 17270676
Am J Ophthalmol. 2014 Sep;158(3):557-66.e1
pubmed: 24879944
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2283-9
pubmed: 27127926
Ophthalmology. 2015 Jul;122(7):1356-65
pubmed: 25972258
Ophthalmology. 2018 Dec;125(12):1913-1928
pubmed: 30060980
Ophthalmology. 2016 May;123(5):1060-79
pubmed: 26952592
Ophthalmol Retina. 2020 Mar;4(3):274-283
pubmed: 31924545
Retina. 2019 Jan;39(1):12-26
pubmed: 30312263
Am J Pathol. 2019 Jul;189(7):1473-1480
pubmed: 31051169
Eye (Lond). 1988;2 ( Pt 5):552-77
pubmed: 2476333
Retina. 2016 Oct;36(10):1806-22
pubmed: 27652913
Ophthalmology. 2011 Apr;118(4):679-86
pubmed: 21035861
Invest Ophthalmol Vis Sci. 2015 Jan 08;56(1):633-9
pubmed: 25574052
J Comp Neurol. 1990 Feb 22;292(4):497-523
pubmed: 2324310
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2655-61
pubmed: 16723483
Ophthalmology. 2010 Feb;117(2):303-12.e1
pubmed: 19815280
Arch Ophthalmol. 2009 Sep;127(9):1168-74
pubmed: 19752426
Retina. 2019 Oct 01;:
pubmed: 31584560
Ophthalmology. 2011 Aug;118(8):1619-25
pubmed: 21550118
Clin Ophthalmol. 2008 Jun;2(2):413-24
pubmed: 19668732
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3456-3463
pubmed: 28702674
Am J Ophthalmol. 2008 Nov;146(5):692-9
pubmed: 18672224
Retina. 2013 Feb;33(2):265-76
pubmed: 23266879
Ophthalmol Retina. 2018 Sep;2(9):914-921
pubmed: 31047226
Invest Ophthalmol Vis Sci. 2020 Jan 23;61(1):2
pubmed: 31995152
Ophthalmology. 2013 Apr;120(4):821-8
pubmed: 23357621

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH